|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, IGH/CCND1, t(11;14)
Test Code17346
CPT Codes
88275, 88271 (x2)
Includes
If results are not possible, the test order may be canceled and replaced by a "Cytogenetic Communication".
Preferred Specimen
5 mL whole blood or 3 mL bone marrow collected in sodium heparin (green-top) tube, or
5x5 mm fresh tissue collected in culture transport media or sterile container with Hanks' or Ringers solution, or
Tissue in Formalin-fixed paraffin-embedded tissue
5x5 mm fresh tissue collected in culture transport media or sterile container with Hanks' or Ringers solution, or
Tissue in Formalin-fixed paraffin-embedded tissue
Minimum Volume
1 mL whole blood or bone marrow • 5x5 mm tissue
Other Acceptable Specimens
Whole blood or bone marrow collected in: Sodium heparin (royal blue-top) or sodium heparin lead-free (tan-top) tube
Instructions
3-5 mL whole blood or 1-3 mL bone marrow collected in a sodium heparin tube, 5x5 mm Fresh tissue in sterile container, Formalin Fixed Paraffin Embedded Tissue
Transport Temperature
Room temperature
Specimen Stability
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Methodology
Fluorescence in situ Hybridization (FISH)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Monday-Sunday Morning
Report available: 5 Days
Report available: 5 Days
Reference Range
Interpretive report
Clinical Significance
This test is performed to detect the IGH-CCND1 fusion, translocation t(11;14) by FISH (fluorescence in situ hybridization). This assay is useful for diagnosis of mantle cell lymphoma and, risk assessment for plasma cell myeloma.
